From Fluid Handling to Dose Control: How Valve Technology Evolved from Process Component to Dose-Control Enabler
semiconductor-digest.com Oct 26, 2026

From Fluid Handling to Dose Control: How Valve Technology Evolved from Process Component to Dose-Control Enabler

AI-summarised brief · reviewed before publication

Jeff DeWitt, lead applications engineer at Swagelok, outlines three evolutionary phases of semiconductor valve technology driven by the tightening demands of atomic‑layer processes. In the “purity” era, valves were evaluated mainly on leak tightness, diaphragm integrity, cycle life and cleanliness. The shift to high‑volume atomic‑layer deposition (ALD) ushered in the “performance” era, where flow‑path geometry, conductance, purgeability and thermal stability became critical to maintain throughput and yield across wafers. The current “precision” era focuses on dose control—the exact number of moles delivered during millisecond‑scale valve‑open pulses in advanced ALD and atomic‑layer etch. At these time scales, minute variations in actuation and conductance drift dominate, making dose regulation a system‑level outcome rather than a function of any single valve.

💡 Why It Matters

  • · Precise mole‑by‑mole dosing is now the bottleneck for scaling 3‑D semiconductor architectures, directly linking valve engineering to device performance and yield.